 Abstract this study investigated the association between asymmetric dimethylogenine, ADMA, levels and disease severity and need for intensive care unit, ICU, admission in patients with SARS-CoV-2 infection. The results suggest that higher ADMA levels are indicative of higher disease severity and need for ICU admission. Additionally, ADMA levels can be used as a predictor of disease progression and poorer outcomes. This article was authored by Amonuela Sozio, Julianne Hanaman, Martina Fabri, and others.